The times they are a-changin’ Prostate October 12, 2023 But not antiquated reimbursement structures. A NCDB analysis demonstrates a steady decline in use of conventional fractionation (i.e., >30 fractions)…
Still buzzin’ after a dozen Prostate October 5, 2023 12-year follow-up of RTOG 0415 confirms noninferior disease-free survival (61.8% v 56.1%) and superior biochemical control (90.1% v 83%) following…
Right on time Head and Neck July 11, 2023 Top Line: Is accelerated fractionation superior to standard fractionation for early glottic cancer?The Study: A single-center randomized trial found that…
